These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22184457)

  • 1. Investigation of figopitant and its metabolites in rat tissue by combining whole-body autoradiography with liquid extraction surface analysis mass spectrometry.
    Schadt S; Kallbach S; Almeida R; Sandel J
    Drug Metab Dispos; 2012 Mar; 40(3):419-25. PubMed ID: 22184457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid extraction surface analysis mass spectrometry (LESA-MS) as a novel profiling tool for drug distribution and metabolism analysis: the terfenadine example.
    Eikel D; Vavrek M; Smith S; Bason C; Yeh S; Korfmacher WA; Henion JD
    Rapid Commun Mass Spectrom; 2011 Dec; 25(23):3587-96. PubMed ID: 22095508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of a liquid extraction based sealing surface sampling probe for mass spectrometric analysis of dried blood spots and mouse whole-body thin tissue sections.
    Van Berkel GJ; Kertesz V
    Anal Chem; 2009 Nov; 81(21):9146-52. PubMed ID: 19817477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of drug distribution images from whole-body thin tissue sections obtained using desorption electrospray ionization tandem mass spectrometry and autoradiography.
    Kertesz V; Van Berkel GJ; Vavrek M; Koeplinger KA; Schneider BB; Covey TR
    Anal Chem; 2008 Jul; 80(13):5168-77. PubMed ID: 18481874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic disposition of casopitant, a potent neurokinin-1 receptor antagonist, in mice, rats, and dogs.
    Miraglia L; Pagliarusco S; Bordini E; Martinucci S; Pellegatti M
    Drug Metab Dispos; 2010 Oct; 38(10):1876-91. PubMed ID: 20622044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of chloroquine and metabolites directly from whole-body animal tissue sections by liquid extraction surface analysis (LESA) and tandem mass spectrometry.
    Parson WB; Koeniger SL; Johnson RW; Erickson J; Tian Y; Stedman C; Schwartz A; Tarcsa E; Cole R; Van Berkel GJ
    J Mass Spectrom; 2012 Nov; 47(11):1420-8. PubMed ID: 23147817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of erlotinib and its metabolites in rat tissue sections by MALDI quadrupole time-of-flight mass spectrometry.
    Signor L; Varesio E; Staack RF; Starke V; Richter WF; Hopfgartner G
    J Mass Spectrom; 2007 Jul; 42(7):900-9. PubMed ID: 17534860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping drug distribution in brain tissue using liquid extraction surface analysis mass spectrometry imaging.
    Swales JG; Tucker JW; Spreadborough MJ; Iverson SL; Clench MR; Webborn PJ; Goodwin RJ
    Anal Chem; 2015 Oct; 87(19):10146-52. PubMed ID: 26350423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure elucidation of three isomeric metabolites of SYN-2836, a novel antifungal agent, in dogs via liquid chromatography/mass spectrometry and liquid chromatography/tandem mass spectrometry methodologies.
    Bu HZ; Poglod M; Micetich RG; Khan JK
    J Mass Spectrom; 1999 Nov; 34(11):1185-94. PubMed ID: 10548812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-performance liquid chromatography-mass spectrometry (HPLC-MS)-based drug metabolite profiling.
    Wilson ID
    Methods Mol Biol; 2011; 708():173-90. PubMed ID: 21207290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid microjunction surface sampling coupled with high-pressure liquid chromatography-electrospray ionization-mass spectrometry for analysis of drugs and metabolites in whole-body thin tissue sections.
    Kertesz V; Van Berkel GJ
    Anal Chem; 2010 Jul; 82(14):5917-21. PubMed ID: 20560529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolic disposition of aprepitant, a substance P receptor antagonist, in rats and dogs.
    Huskey SE; Dean BJ; Doss GA; Wang Z; Hop CE; Anari R; Finke PE; Robichaud AJ; Zhang M; Wang B; Strauss JR; Cunningham PK; Feeney WP; Franklin RB; Baillie TA; Chiu SH
    Drug Metab Dispos; 2004 Feb; 32(2):246-58. PubMed ID: 14744948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo investigation of metabolic fate of rifampicin using an optimized sample preparation approach and modern tools of liquid chromatography-mass spectrometry.
    Prasad B; Singh S
    J Pharm Biomed Anal; 2009 Oct; 50(3):475-90. PubMed ID: 19535209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative estimation of circulating metabolites without synthetic standards by ultra-high-performance liquid chromatography/high resolution accurate mass spectrometry in combination with UV correction.
    Yang Y; Grubb MF; Luk CE; Humphreys WG; Josephs JL
    Rapid Commun Mass Spectrom; 2011 Nov; 25(21):3245-51. PubMed ID: 22006386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absorption, distribution, metabolism, and excretion of atevirdine in the rat.
    Chang M; Sood VK; Wilson GJ; Kloosterman DA; Sanders PE; Schuette MR; Judy RW; Voorman RL; Maio SM; Slatter JG
    Drug Metab Dispos; 1998 Oct; 26(10):1008-18. PubMed ID: 9763407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition and metabolism of radiolabeled casopitant in humans.
    Pellegatti M; Bordini E; Fizzotti P; Roberts A; Johnson BM
    Drug Metab Dispos; 2009 Aug; 37(8):1635-45. PubMed ID: 19420128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of metabolites in rat plasma after intravenous administration of salvianolic acid A by liquid chromatography/time-of-flight mass spectrometry and liquid chromatography/ion trap mass spectrometry.
    Shen Y; Wang X; Xu L; Liu X; Chao R
    Rapid Commun Mass Spectrom; 2009 Jun; 23(12):1810-6. PubMed ID: 19437443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-dimensional liquid chromatography/mass spectrometry set-up for structural elucidation of metabolites in complex biological matrices.
    Kiffe M; Graf D; Trunzer M
    Rapid Commun Mass Spectrom; 2007; 21(6):961-70. PubMed ID: 17299833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue distribution and characterization of drug-related material in rats and dogs after repeated oral administration of casopitant.
    Pagliarusco S; Martinucci S; Bordini E; Miraglia L; Cufari D; Ferrari L; Pellegatti M
    Drug Metab Dispos; 2011 Feb; 39(2):283-93. PubMed ID: 20978104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the metabolism of the Delta9-tetrahydrocannabinol precursor Delta9-tetrahydrocannabinolic acid A (Delta9-THCA-A) in rat using LC-MS/MS, LC-QTOF MS and GC-MS techniques.
    Jung J; Meyer MR; Maurer HH; Neusüss C; Weinmann W; Auwärter V
    J Mass Spectrom; 2009 Oct; 44(10):1423-33. PubMed ID: 19728318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.